Abstract:Arcade Arakaza, Li Zou, Jianwen Zhu Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China Correspondence: Li Zou, Email Background: Placenta accreta spectrum (PAS) is the most common obstetric complication in current obstetrics in which the placenta is fully or partially attached to the uterine myometrial layer at delivery. This is commonly due to the deficiency of the uterine interface between the uterine endometrial and myometrial layers leading to abnormal decidualization at the uterine scar area, which permits the abnormally placental anchoring villous and trophoblasts, deeply invade the myometrium. The prevalence of PAS is globally at rising trends every day in modern obstetrics originally due to the high increasing rate of cesarean sections, placenta previa, and assisted reproductive technology (ART). Thus, the early and precise diagnosis of PAS is imperative to prevent maternal intrapartum or postpartum bleeding complications. Objective: The main aim of this review is to debate the current challenges and controversies in the routine diagnosis of PAS diseases in obstetrics. Data Source: We retrospectively reviewed the recent articles on different methods of diagnosing PAS in PubMed, Google Scholar, Web of Science, Medline, Embase, and other website databases. Results: Despite that, the standard ultrasound is a reliable and key tool for the diagnosis of PAS, the lack of ultrasound features does not exclude the diagnosis of PAS. Therefore, clinical assessment of risk factors, MRI tests, serological markers, and placental histopathological tests are also indispensable for the prediction of PAS. Previously, limited studies reached a high sensitivity rate of diagnosis PAS in appropriate cases, while many studies recommended the inclusion of different diagnosis methods to improve the diagnosis accuracy. Conclusion: A multidisciplinary squad with well-experienced obstetricians, radiologists, and histopathologists should be involved in the establishment of the early and conclusive diagnosis of PAS. Keywords: placenta accreta spectrum, PAS, diagnosis, challenges and controversies, obstetrics, review Placenta accreta refers to a variety of aberrant placentation disorders resulting in complete or partial retention of the placenta at delivery. Traditionally, it was divided into three pathologic categories according to the invasiveness of the placenta: placenta accreta when anchoring villi closely adhere to the superficial myometrium without interrupting decidua, placenta increta when the placental villi invade the myometrium, and placenta percreta when placental villi invade the myometrium and through the whole uterine wall reach the serosa, even the surrounding tissues, and organs. 1–4 In fact, the profundity degree of placental villous tissues invading the myometrium varies greatly. Therefore, current pathologists have avoided the traditional term and defined this spectrum disorder as placenta accreta spectrum (PAS) disorders, including both morbidly adherent placenta (MAP) covering placenta accreta, and abnormally invasive placenta (AIP) covering placenta increta and placenta percreta. 5 The standardized clinical classification and new terminology of PAS including all grades of abnormal placentation descriptively substituted the traditional categorical nomenclature (placenta accreta, increta, percreta) with a pathologic grading classification recently proposed by FIGO (International Federation of Gynaecology and Obstetrics) (Figure 1). 4,6,7 Figure 1 Histologic grading classification of placenta accreta spectrum (PAS) disorders. (PAS Grade 1) Abnormally invasive placenta (placenta accreta). (PAS Grade 2) Superficial invasion of the placenta (placenta increta). (PAS Grade 3A) Deep invasion of the placenta with conservation of less than 25% of the wall thickness relative to the detached myometrium. (PAS Grade 3B) When there is invasion of the urinary bladder by the placenta. (PAS Grade 3C) When there is invasion of other pelvic tissue/organs by the placenta. (PAS Grade 3D) Deep invasion of the placenta with disturbance of the serosa (placenta percreta). (PAS Grade 3E) Deep invasion of the placenta into nearby organs or tissues commonly the bladder (PAS Grade 3B) or other extra-uterine fibro adipose tissues in the parametrium (PAS Grade 3C). Note : PAS Grades 3B and 3C are pathologically inserted in PAS Grade 3E. PAS was first reported in 1927 by Irving et al with an incidence of only 0.12 in 1000 women. 1 In recent years, its incidence in the United States has raised about 13-fold due to a rapidly ascending rate of cesarean deliveries from -Abstract Truncated-

Current understanding of the pathogenesis of placenta accreta spectrum disorder with focus on mitochondrial function

What We Know about Placenta Accreta Spectrum (PAS)

The Underlying Molecular Mechanisms of the Placenta Accreta Spectrum: A Narrative Review

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers

An integral role of mitochondrial function in the pathophysiology of preeclampsia

Risk factors for placenta accreta spectrum in pregnancies conceived after frozen–thawed embryo transfer in a hormone replacement cycle

Research progress on pathogenesis of placenta accreta spectrum

Risk factors for non-previa placenta accreta spectrum in pregnancies conceived through frozen embryo transfer during a hormone replacement cycle in Japan

Single-cell and spatial transcriptomics reveal alterations in trophoblasts at invasion sites and disturbed myometrial immune microenvironment in placenta accreta spectrum disorders

Placenta Accreta Spectrum (PAS): Diagnosis, Clinical Presentation, Therapeutic Approaches, and Clinical Outcomes

Revisiting preeclampsia: a metabolic disorder of the placenta

Placenta Accreta Spectrum Diagnosis Challenges and Controversies in Current Obstetrics: A Review

Microcellular approach for the pathogenesis of placenta accreta spectrum inflammatory versus apoptotic pathways; a thorough look on Treg, dNK and VEGF

Risk Profiling In Vitro Fertilization Pregnancies that Develop Placenta Accreta Spectrum

Assisted reproductive technology-associated risk factors for placenta accreta spectrum after vaginal delivery

Abnormal Placental Development Induced by Repeated Cesarean Sections: Investigating an Animal Model of Placenta Accreta Spectrum Disorders

Spatial proteomics and transcriptomics of placenta accreta spectrum

Addressing Diagnosis, Management, and Complication Challenges in Placenta Accreta Spectrum Disorder: A Descriptive Study

Current state of interventional procedures to treat pernicious placenta previa accompanied by placenta accreta spectrum: A review

Animal models of the placenta accreta spectrum: current status and further perspectives